On (b)(6) 2020, a patient (pt) in (b)(6) reported inflammation in the left eye (os) while wearing an acuvue® oasys® brand contact lens.In (b)(6) 2020, the pt presented to an eye care provider (ecp) with pain os and was diagnosed with iritis os.The pt was prescribed rinderon drops (unspecified dosage, frequency, duration).The pt was instructed to discontinue contact lens wear until the inflammation resolved and to return to the ecp for follow-up (unspecified date).In (b)(6) 2020, the pt returned to the ecp for follow-up and the os was recovered.There was no further instruction to return or to discontinue lens wear.Currently, the pt has no problem with the os and is wearing daily disposable contact lenses.The pt refused to provide further information.No additional information has been received.No further information is expected.The os suspect product was discarded.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot l003t9t was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
|